PDUFA target action date of August 28, 2024
MAA validated and accepted for review by EMA in December 2023
https://www.globenewswire.com/news-release/2024/02/28/2836879/0/en/Applied-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Govorestat-for-the-Treatment-of-Classic-Galactosemia.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.